SlideShare una empresa de Scribd logo
1 de 63
SYNCOPE: WHAT HAPPENS WHEN YOUR LIGHTS GO OUT  ? Syed Raza MD,MRCP (UK),FCCP, Dip.Card (UK)
COMMON SCENARIO ! ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Case    Mrs L, 64yo F                 66yo F         ,        Mrs K,  59yo F               Mrs M,  85yo F           ? Seizure ?  FA L L ? Orthostasis ? Neurocardiogenic
 
 
 
 
 
 
 
 
Objectives ,[object Object],[object Object],[object Object],[object Object],[object Object]
Syncope: A Symptom, Not a Diagnosis ,[object Object],[object Object],[object Object],[object Object],[object Object],Underlying mechanism:  transient global cerebral hypoperfusion.
Impact of Syncope 1 Kenny RA, Kapoor WN. In: Benditt D, et al. eds.  The Evaluation and   Treatment of Syncope . Futura;2003:23-27. 2 Kapoor W.  Medicine . 1990;69:160-175. 3 Brignole M, et al.  Europace . 2003;5:293-298. 4  Blanc J-J, et al.  Eur Heart  J . 2002;23:815-820. 5 Campbell A, et al.  Age and Ageing . 1981;10:264-270. ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
THE  COST ,[object Object],[object Object],[object Object]
Incidence Rates of Syncope According to Age and Sex Soteriades, E. et al. N Engl J Med 2002;347:878-885
 
Classification Syncope Neurally Mediated 34% Vasovagal Carotid Sinus Situational Glossopharyngeal Neuralgia Cerebrovascular Autonomic Failure Cardiac Mediated 18% Arrythmia Srtructural Heart Disease Cardiopulmonary Disease Others 47% Orthostatic Hypotension Idiopathic Medications Psychiatric
Causes of syncope*   ,[object Object],[object Object],[object Object],[object Object],[object Object],*  Data pooled from 4 population studies n=1640 patients
Neurally Mediated Syncope ,[object Object],[object Object],[object Object],[object Object]
Neurally Mediated Syncope (autonomic failure) ,[object Object],[object Object]
Neuro-Cardiogenic Syncope ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Pathophysiology ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Carotid Sinus Syndrome ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Carotid Sinus Syncope and Autonomic Dysfunction Freeman, M.  Neurogenic Orthostatic Hypotension.  NEJM 2008; 358: 616
 
POSTURAL  BP
 
Postural Blood Pressure ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Orthostatic Hypotension ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
POSTURAL ORTHOSTATIC TACHYCARDIA  SYNDROME  (POTS) ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Initial evaluation: History ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Diagnostic tests ,[object Object],[object Object],[object Object]
Carotid Sinus Massage Protocol ,[object Object],[object Object],[object Object],[object Object]
Carotid Sinus Massage ,[object Object],[object Object],[object Object],[object Object]
Positive CSM Test ,[object Object],[object Object],[object Object]
TILT TABLE TEST
Tilt Table Test In Action
Indications for Tilt Table Testing ,[object Object],[object Object],[object Object],[object Object]
Upright Tilt Table Test ,[object Object],[object Object]
Tilt Table Testing ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Normal test
Cardioinhibitory response
Vasodepressor response BP drops from 150/70 to 50/30 but heart rate stays same
Mixed response BP drops from 150/60 to 50/20 while HR drops from 65 to 30bpm
 
Orthostatic hypotension steady drop in BP and rise in HR
Heart Monitoring Options Syncope Occurs Infrequently,  Long-term Monitoring is Likely to be Most Effective ILR MCOT External Loop Recorder Typical Event Recorder Holter Monitor 12-Lead 2 Days 7 Days 30+ Days 36 Months 10 Seconds ILR = insertable loop recorder MCOT= mobile cardiac outpatient telemetry
 
Everything is spinning
MANAGEMENT ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Postural hypotension ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Pharmacological  therapy ,[object Object],[object Object],[object Object],[object Object],[object Object]
Management of Neurally Mediated Syncope Grubb BP.  NEJM.  2005.  352(10): 1004-1010
INDICATION  FOR  PACEMAKER  ,[object Object],[object Object],[object Object]
What are the indications for pacemaker therapy in neurocardiogenic syncope? ,[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],The North American Vasovagal Pacemaker Study (VPS) ,[object Object],[object Object],[object Object],[object Object],Primary outcome: first recurrence of syncope ,[object Object],[object Object],J. Am. Coll Cardiol . 1999;33:16-20 Pacemaker No pacemaker Recurrence of Syncope 6/27 (22%) 19/27  (70%) Time to recurrence 112 days 54 days
Soteriades E et al. N Engl J Med 2002;347:878-885 Overall Survival of Participants with Syncope, According to Cause, and Participants without Syncope
Driving Implications Group 1 Entitlement Group 2 Entitlement Simple faint –definite provocation with prodromal symptoms No driving restrictions No driving restrictions Unexplained syncope with low risk of recurrence Can drive 4 weeks after the event Can drive 3 months after the event Unexplained syncope & high risk of recurrence A abnormal ECG B structural heart disease C syncope at the wheel or results in injury D more than 1 episode in last 6 months Can drive 4 weeks after the event if cause identified and treated If no cause – 6 months off Can drive after 3 months if the cause identified and treated If no cause, licence revoked for year Loss of consciousness with no clinical pointers Full neuro/cardiac Ix with no pointers Licence revoked for 6 months Licence revoked for 1 year Cough syncope Stop driving until symptoms controlled Stop driving If smokes or respiratory disease have to be controlled for 5 years
SUMMARY ,[object Object],[object Object],[object Object],[object Object],[object Object]
 
ANY  QUESTION ??
 

Más contenido relacionado

La actualidad más candente

La actualidad más candente (20)

Syncope iman
 Syncope iman Syncope iman
Syncope iman
 
Syncope
SyncopeSyncope
Syncope
 
Approach to Syncope
Approach to SyncopeApproach to Syncope
Approach to Syncope
 
Primary PCI
Primary PCIPrimary PCI
Primary PCI
 
Aortic regurgitation
Aortic regurgitationAortic regurgitation
Aortic regurgitation
 
IImplantable Cardioverter Defibrillators (ICDs) - Dr Prithvi puwar
IImplantable Cardioverter Defibrillators (ICDs) - Dr Prithvi puwarIImplantable Cardioverter Defibrillators (ICDs) - Dr Prithvi puwar
IImplantable Cardioverter Defibrillators (ICDs) - Dr Prithvi puwar
 
Syncope
SyncopeSyncope
Syncope
 
Cardiac tamponade
Cardiac tamponadeCardiac tamponade
Cardiac tamponade
 
Ventricular tachycardia
Ventricular tachycardiaVentricular tachycardia
Ventricular tachycardia
 
Acute Coronary Syndrome and the ECG
Acute Coronary Syndrome and the ECGAcute Coronary Syndrome and the ECG
Acute Coronary Syndrome and the ECG
 
Syncope dr yate
Syncope  dr yateSyncope  dr yate
Syncope dr yate
 
Pericardial diseases
Pericardial  diseasesPericardial  diseases
Pericardial diseases
 
Vpcs
VpcsVpcs
Vpcs
 
Jugular Venous Pressure (JVP) Jugular Venous Pulse
Jugular Venous Pressure (JVP) Jugular Venous PulseJugular Venous Pressure (JVP) Jugular Venous Pulse
Jugular Venous Pressure (JVP) Jugular Venous Pulse
 
Bradyarrhythmias
BradyarrhythmiasBradyarrhythmias
Bradyarrhythmias
 
Aortic dissection nikku ppt
Aortic dissection nikku pptAortic dissection nikku ppt
Aortic dissection nikku ppt
 
ECG Basics
ECG BasicsECG Basics
ECG Basics
 
Brugada syndrome
Brugada syndromeBrugada syndrome
Brugada syndrome
 
Mitral valve disease
Mitral valve diseaseMitral valve disease
Mitral valve disease
 
Bradyarrythmia
BradyarrythmiaBradyarrythmia
Bradyarrythmia
 

Destacado (19)

Syncope
SyncopeSyncope
Syncope
 
Syncope Assessment and Management
Syncope Assessment and ManagementSyncope Assessment and Management
Syncope Assessment and Management
 
Syncope medical emergency
Syncope medical emergencySyncope medical emergency
Syncope medical emergency
 
Syncope
SyncopeSyncope
Syncope
 
Syncope A Case Presentation Edited
Syncope A Case Presentation EditedSyncope A Case Presentation Edited
Syncope A Case Presentation Edited
 
Vasovagal Syncope
Vasovagal SyncopeVasovagal Syncope
Vasovagal Syncope
 
Syncope
SyncopeSyncope
Syncope
 
(2014-11-25) Manejo del sincope (ppt)
(2014-11-25) Manejo del sincope (ppt)(2014-11-25) Manejo del sincope (ppt)
(2014-11-25) Manejo del sincope (ppt)
 
Syncope
SyncopeSyncope
Syncope
 
3 Dizziness And Syncope. Karen Hauer, Md
3 Dizziness And Syncope. Karen Hauer, Md3 Dizziness And Syncope. Karen Hauer, Md
3 Dizziness And Syncope. Karen Hauer, Md
 
Sincope
SincopeSincope
Sincope
 
Sincope
SincopeSincope
Sincope
 
Vasovagal Syncope
Vasovagal SyncopeVasovagal Syncope
Vasovagal Syncope
 
Mal súbito
Mal súbitoMal súbito
Mal súbito
 
Vasovagal syncope management Mexico City 2016
Vasovagal syncope management Mexico City 2016Vasovagal syncope management Mexico City 2016
Vasovagal syncope management Mexico City 2016
 
Internship powerpoint
Internship powerpointInternship powerpoint
Internship powerpoint
 
NEUROCARDIOGENIC SYNCOPE ppt
NEUROCARDIOGENIC SYNCOPE ppt NEUROCARDIOGENIC SYNCOPE ppt
NEUROCARDIOGENIC SYNCOPE ppt
 
Syncope 1
Syncope 1Syncope 1
Syncope 1
 
Guia de actuación 2012: Síncope
Guia de actuación 2012: SíncopeGuia de actuación 2012: Síncope
Guia de actuación 2012: Síncope
 

Similar a Syncope

Similar a Syncope (20)

Syncopeneurotalk2011 110718115506-phpapp01(1)
Syncopeneurotalk2011 110718115506-phpapp01(1)Syncopeneurotalk2011 110718115506-phpapp01(1)
Syncopeneurotalk2011 110718115506-phpapp01(1)
 
SYNCOPE..pptx
SYNCOPE..pptxSYNCOPE..pptx
SYNCOPE..pptx
 
Fainting: Causes and Ways to Minimize Risk
Fainting: Causes and Ways to Minimize RiskFainting: Causes and Ways to Minimize Risk
Fainting: Causes and Ways to Minimize Risk
 
3 dizziness and syncope. karen hauer, md
3 dizziness and syncope. karen hauer, md3 dizziness and syncope. karen hauer, md
3 dizziness and syncope. karen hauer, md
 
Syncope
SyncopeSyncope
Syncope
 
Death by Neurological Criteria and Organ Donation: Bill Knight
Death by Neurological Criteria and Organ Donation: Bill KnightDeath by Neurological Criteria and Organ Donation: Bill Knight
Death by Neurological Criteria and Organ Donation: Bill Knight
 
Syncope
SyncopeSyncope
Syncope
 
Vertigo & Dizziness
Vertigo & DizzinessVertigo & Dizziness
Vertigo & Dizziness
 
STROKE
STROKESTROKE
STROKE
 
Paediatric Cardiology for General Paediatrics.ppt
Paediatric Cardiology for General Paediatrics.pptPaediatric Cardiology for General Paediatrics.ppt
Paediatric Cardiology for General Paediatrics.ppt
 
Seminar syncope
Seminar  syncopeSeminar  syncope
Seminar syncope
 
NSG 6420_Grand_Round 2_Amougou_Yves
NSG 6420_Grand_Round 2_Amougou_YvesNSG 6420_Grand_Round 2_Amougou_Yves
NSG 6420_Grand_Round 2_Amougou_Yves
 
Cerebral Venous Thrombosis
Cerebral Venous ThrombosisCerebral Venous Thrombosis
Cerebral Venous Thrombosis
 
Cerebrovascular Accident
Cerebrovascular AccidentCerebrovascular Accident
Cerebrovascular Accident
 
Anaesthesia and ihd
Anaesthesia and ihdAnaesthesia and ihd
Anaesthesia and ihd
 
Stroke
StrokeStroke
Stroke
 
Management of Hypertension in Critical Illness
Management of Hypertension in Critical IllnessManagement of Hypertension in Critical Illness
Management of Hypertension in Critical Illness
 
Sick Sinus Syndrome
Sick Sinus SyndromeSick Sinus Syndrome
Sick Sinus Syndrome
 
TBI Management
TBI ManagementTBI Management
TBI Management
 
Why seizure not just epilepsy as it used to?
Why seizure not just epilepsy as it used to?Why seizure not just epilepsy as it used to?
Why seizure not just epilepsy as it used to?
 

Más de SMSRAZA

Do Not Resuscitate Orders : What They Mean ?
Do Not Resuscitate Orders : What They Mean ?Do Not Resuscitate Orders : What They Mean ?
Do Not Resuscitate Orders : What They Mean ?SMSRAZA
 
Heat and heart
Heat  and heartHeat  and heart
Heat and heartSMSRAZA
 
Hypertension - Deciphered
Hypertension - DecipheredHypertension - Deciphered
Hypertension - DecipheredSMSRAZA
 
ARRHYTHMIA - WHAT YOU NEED TO KNOW FOR ACLS.
ARRHYTHMIA - WHAT YOU NEED TO KNOW FOR ACLS.ARRHYTHMIA - WHAT YOU NEED TO KNOW FOR ACLS.
ARRHYTHMIA - WHAT YOU NEED TO KNOW FOR ACLS.SMSRAZA
 
Hypertensive crisis
Hypertensive crisisHypertensive crisis
Hypertensive crisisSMSRAZA
 
Hypertensive crisis
Hypertensive crisisHypertensive crisis
Hypertensive crisisSMSRAZA
 
Acute medical emergencies
Acute  medical emergenciesAcute  medical emergencies
Acute medical emergenciesSMSRAZA
 
Heart failure symposium
Heart failure symposiumHeart failure symposium
Heart failure symposiumSMSRAZA
 
Atrial fibrillation
Atrial  fibrillation Atrial  fibrillation
Atrial fibrillation SMSRAZA
 
Ace inhibitor
Ace inhibitorAce inhibitor
Ace inhibitorSMSRAZA
 
Ace inhibitor :From Venom to Drug
Ace inhibitor :From Venom to DrugAce inhibitor :From Venom to Drug
Ace inhibitor :From Venom to DrugSMSRAZA
 
BALANCING THROMBOSIS AND BLEEDING RISKS
BALANCING THROMBOSIS AND BLEEDING  RISKSBALANCING THROMBOSIS AND BLEEDING  RISKS
BALANCING THROMBOSIS AND BLEEDING RISKSSMSRAZA
 
Chest pain presentation
Chest pain presentationChest pain presentation
Chest pain presentationSMSRAZA
 
Early repolarization: Safety Profile
Early repolarization: Safety ProfileEarly repolarization: Safety Profile
Early repolarization: Safety ProfileSMSRAZA
 
Management of congenital heart disease in infants
Management of congenital heart disease in infantsManagement of congenital heart disease in infants
Management of congenital heart disease in infantsSMSRAZA
 
Commotio cordis
Commotio  cordisCommotio  cordis
Commotio cordisSMSRAZA
 
Commotio cordis
Commotio  cordisCommotio  cordis
Commotio cordisSMSRAZA
 
TACHYARRHYTHMIA
TACHYARRHYTHMIATACHYARRHYTHMIA
TACHYARRHYTHMIASMSRAZA
 
Tachyarrhythmia
TachyarrhythmiaTachyarrhythmia
TachyarrhythmiaSMSRAZA
 

Más de SMSRAZA (20)

Do Not Resuscitate Orders : What They Mean ?
Do Not Resuscitate Orders : What They Mean ?Do Not Resuscitate Orders : What They Mean ?
Do Not Resuscitate Orders : What They Mean ?
 
Heat and heart
Heat  and heartHeat  and heart
Heat and heart
 
Hypertension - Deciphered
Hypertension - DecipheredHypertension - Deciphered
Hypertension - Deciphered
 
ARRHYTHMIA - WHAT YOU NEED TO KNOW FOR ACLS.
ARRHYTHMIA - WHAT YOU NEED TO KNOW FOR ACLS.ARRHYTHMIA - WHAT YOU NEED TO KNOW FOR ACLS.
ARRHYTHMIA - WHAT YOU NEED TO KNOW FOR ACLS.
 
Hypertensive crisis
Hypertensive crisisHypertensive crisis
Hypertensive crisis
 
Hypertensive crisis
Hypertensive crisisHypertensive crisis
Hypertensive crisis
 
Acute medical emergencies
Acute  medical emergenciesAcute  medical emergencies
Acute medical emergencies
 
Heart failure symposium
Heart failure symposiumHeart failure symposium
Heart failure symposium
 
Atrial fibrillation
Atrial  fibrillation Atrial  fibrillation
Atrial fibrillation
 
Ace inhibitor
Ace inhibitorAce inhibitor
Ace inhibitor
 
Ace inhibitor :From Venom to Drug
Ace inhibitor :From Venom to DrugAce inhibitor :From Venom to Drug
Ace inhibitor :From Venom to Drug
 
BALANCING THROMBOSIS AND BLEEDING RISKS
BALANCING THROMBOSIS AND BLEEDING  RISKSBALANCING THROMBOSIS AND BLEEDING  RISKS
BALANCING THROMBOSIS AND BLEEDING RISKS
 
Chest pain presentation
Chest pain presentationChest pain presentation
Chest pain presentation
 
Early repolarization: Safety Profile
Early repolarization: Safety ProfileEarly repolarization: Safety Profile
Early repolarization: Safety Profile
 
Management of congenital heart disease in infants
Management of congenital heart disease in infantsManagement of congenital heart disease in infants
Management of congenital heart disease in infants
 
Bmj
BmjBmj
Bmj
 
Commotio cordis
Commotio  cordisCommotio  cordis
Commotio cordis
 
Commotio cordis
Commotio  cordisCommotio  cordis
Commotio cordis
 
TACHYARRHYTHMIA
TACHYARRHYTHMIATACHYARRHYTHMIA
TACHYARRHYTHMIA
 
Tachyarrhythmia
TachyarrhythmiaTachyarrhythmia
Tachyarrhythmia
 

Último

PULMONARY EDEMA AND ITS MANAGEMENT.pdf
PULMONARY EDEMA AND  ITS  MANAGEMENT.pdfPULMONARY EDEMA AND  ITS  MANAGEMENT.pdf
PULMONARY EDEMA AND ITS MANAGEMENT.pdfDolisha Warbi
 
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
COVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptxCOVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptx
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptxBibekananda shah
 
maternal mortality and its causes and how to reduce maternal mortality
maternal mortality and its causes and how to reduce maternal mortalitymaternal mortality and its causes and how to reduce maternal mortality
maternal mortality and its causes and how to reduce maternal mortalityhardikdabas3
 
Nutrition of OCD for my Nutritional Neuroscience Class
Nutrition of OCD for my Nutritional Neuroscience ClassNutrition of OCD for my Nutritional Neuroscience Class
Nutrition of OCD for my Nutritional Neuroscience Classmanuelazg2001
 
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptxPresentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptxpdamico1
 
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisVarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisGolden Helix
 
Tans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptxTans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptxKezaiah S
 
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfLippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfSreeja Cherukuru
 
Case Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxCase Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxNiranjan Chavan
 
epilepsy and status epilepticus for undergraduate.pptx
epilepsy and status epilepticus  for undergraduate.pptxepilepsy and status epilepticus  for undergraduate.pptx
epilepsy and status epilepticus for undergraduate.pptxMohamed Rizk Khodair
 
The next social challenge to public health: the information environment.pptx
The next social challenge to public health:  the information environment.pptxThe next social challenge to public health:  the information environment.pptx
The next social challenge to public health: the information environment.pptxTina Purnat
 
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxSYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxdrashraf369
 
Glomerular Filtration and determinants of glomerular filtration .pptx
Glomerular Filtration and  determinants of glomerular filtration .pptxGlomerular Filtration and  determinants of glomerular filtration .pptx
Glomerular Filtration and determinants of glomerular filtration .pptxDr.Nusrat Tariq
 
systemic bacteriology (7)............pptx
systemic bacteriology (7)............pptxsystemic bacteriology (7)............pptx
systemic bacteriology (7)............pptxEyobAlemu11
 
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
PNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdfPNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdf
PNEUMOTHORAX AND ITS MANAGEMENTS.pdfDolisha Warbi
 
Radiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxRadiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxDr. Dheeraj Kumar
 
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Badalona Serveis Assistencials
 
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdfSGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdfHongBiThi1
 
Giftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-KnowledgeGiftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-Knowledgeassessoriafabianodea
 
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdfMedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdfSasikiranMarri
 

Último (20)

PULMONARY EDEMA AND ITS MANAGEMENT.pdf
PULMONARY EDEMA AND  ITS  MANAGEMENT.pdfPULMONARY EDEMA AND  ITS  MANAGEMENT.pdf
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
 
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
COVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptxCOVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptx
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
 
maternal mortality and its causes and how to reduce maternal mortality
maternal mortality and its causes and how to reduce maternal mortalitymaternal mortality and its causes and how to reduce maternal mortality
maternal mortality and its causes and how to reduce maternal mortality
 
Nutrition of OCD for my Nutritional Neuroscience Class
Nutrition of OCD for my Nutritional Neuroscience ClassNutrition of OCD for my Nutritional Neuroscience Class
Nutrition of OCD for my Nutritional Neuroscience Class
 
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptxPresentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
 
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisVarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
 
Tans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptxTans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptx
 
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfLippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
 
Case Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxCase Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptx
 
epilepsy and status epilepticus for undergraduate.pptx
epilepsy and status epilepticus  for undergraduate.pptxepilepsy and status epilepticus  for undergraduate.pptx
epilepsy and status epilepticus for undergraduate.pptx
 
The next social challenge to public health: the information environment.pptx
The next social challenge to public health:  the information environment.pptxThe next social challenge to public health:  the information environment.pptx
The next social challenge to public health: the information environment.pptx
 
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxSYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
 
Glomerular Filtration and determinants of glomerular filtration .pptx
Glomerular Filtration and  determinants of glomerular filtration .pptxGlomerular Filtration and  determinants of glomerular filtration .pptx
Glomerular Filtration and determinants of glomerular filtration .pptx
 
systemic bacteriology (7)............pptx
systemic bacteriology (7)............pptxsystemic bacteriology (7)............pptx
systemic bacteriology (7)............pptx
 
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
PNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdfPNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdf
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
 
Radiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxRadiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptx
 
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
 
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdfSGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
SGK HÓA SINH NĂNG LƯỢNG SINH HỌC 2006.pdf
 
Giftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-KnowledgeGiftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-Knowledge
 
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdfMedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
 

Syncope

  • 1. SYNCOPE: WHAT HAPPENS WHEN YOUR LIGHTS GO OUT ? Syed Raza MD,MRCP (UK),FCCP, Dip.Card (UK)
  • 2.
  • 3. Case Mrs L, 64yo F 66yo F , Mrs K, 59yo F Mrs M, 85yo F ? Seizure ? FA L L ? Orthostasis ? Neurocardiogenic
  • 4.  
  • 5.  
  • 6.  
  • 7.  
  • 8.  
  • 9.  
  • 10.  
  • 11.  
  • 12.
  • 13.
  • 14.
  • 15.
  • 16. Incidence Rates of Syncope According to Age and Sex Soteriades, E. et al. N Engl J Med 2002;347:878-885
  • 17.  
  • 18. Classification Syncope Neurally Mediated 34% Vasovagal Carotid Sinus Situational Glossopharyngeal Neuralgia Cerebrovascular Autonomic Failure Cardiac Mediated 18% Arrythmia Srtructural Heart Disease Cardiopulmonary Disease Others 47% Orthostatic Hypotension Idiopathic Medications Psychiatric
  • 19.
  • 20.
  • 21.
  • 22.
  • 23.
  • 24.
  • 25. Carotid Sinus Syncope and Autonomic Dysfunction Freeman, M. Neurogenic Orthostatic Hypotension. NEJM 2008; 358: 616
  • 26.  
  • 28.  
  • 29.
  • 30.
  • 31.
  • 32.
  • 33.
  • 34.
  • 35.
  • 36.
  • 38. Tilt Table Test In Action
  • 39.
  • 40.
  • 41.
  • 44. Vasodepressor response BP drops from 150/70 to 50/30 but heart rate stays same
  • 45. Mixed response BP drops from 150/60 to 50/20 while HR drops from 65 to 30bpm
  • 46.  
  • 47. Orthostatic hypotension steady drop in BP and rise in HR
  • 48. Heart Monitoring Options Syncope Occurs Infrequently, Long-term Monitoring is Likely to be Most Effective ILR MCOT External Loop Recorder Typical Event Recorder Holter Monitor 12-Lead 2 Days 7 Days 30+ Days 36 Months 10 Seconds ILR = insertable loop recorder MCOT= mobile cardiac outpatient telemetry
  • 49.  
  • 51.
  • 52.
  • 53.
  • 54. Management of Neurally Mediated Syncope Grubb BP. NEJM. 2005. 352(10): 1004-1010
  • 55.
  • 56.
  • 57.
  • 58. Soteriades E et al. N Engl J Med 2002;347:878-885 Overall Survival of Participants with Syncope, According to Cause, and Participants without Syncope
  • 59. Driving Implications Group 1 Entitlement Group 2 Entitlement Simple faint –definite provocation with prodromal symptoms No driving restrictions No driving restrictions Unexplained syncope with low risk of recurrence Can drive 4 weeks after the event Can drive 3 months after the event Unexplained syncope & high risk of recurrence A abnormal ECG B structural heart disease C syncope at the wheel or results in injury D more than 1 episode in last 6 months Can drive 4 weeks after the event if cause identified and treated If no cause – 6 months off Can drive after 3 months if the cause identified and treated If no cause, licence revoked for year Loss of consciousness with no clinical pointers Full neuro/cardiac Ix with no pointers Licence revoked for 6 months Licence revoked for 1 year Cough syncope Stop driving until symptoms controlled Stop driving If smokes or respiratory disease have to be controlled for 5 years
  • 60.
  • 61.  
  • 63.  

Notas del editor

  1. 1 Kenny RA, Kapoor WN. Epidemiology and social costs. In: Benditt D, Blanc J-J, et al. eds. The Evaluation and Treatment of Syncope . Elmsford, NY: Futura;2003:23-27. 2 Kapoor W. Evaluation and outcome of patients with syncope. Medicine . 1990;69:160-175. 3 Brignole M, Disertori M, Menozzi C, et al. Management of syncope referred urgently to general hospitals with and without syncope units. Europace . 2003;5:293-298. 4 Blanc J-J, L’ Her C, Touiza A, et al. Prospective evaluation and outcome of patients admitted for syncope over a 1 year period. Eur Heart J . 2002;23:815-820. 5 Campbell A, Reinken J, Allan B, et al. Falls in old age: A study of frequency and related clinical factors. Age and Ageing . 1981;10:264-270.
  2. There is severe impairment of neurocardiovascular reflex which leeds to pooling of a significant of blood in the leg vessels.
  3. Stimulation of baro receptors in the carotid body would send neuronal signals to NTS in the brain stem via glossopharyngeal nerve.This inturn would lead to increased parasympathetic nervous tone, inhibiting SA and AV node causing bradycardia.There is also sympathetic withdrawl leading to vasodilataion and hypotension.
  4. Common in elderly and they are most vulnerable due to .. Decreased baro receptor …
  5. Also known as POTS is seen in younger women who usually present dizzyness or faint on sudden standing.
  6. Figure 2. Overall Survival of Participants with Syncope, According to Cause, and Participants without Syncope. P<0.001 for the comparison between participants with and those without syncope. The category "Vasovagal and other causes" includes vasovagal, orthostatic, medication-induced, and other, infrequent causes of syncope.